(18)F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature

Cardiac tumors are a very rare condition. Mostly, they are benign tumors (75%), with myxomas being the most frequent. The remaining 25% are malignant; either primary malignant sarcoma or secondary metastases. Given the small number of cases reported and the lack of prospective and randomized clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Saponara, Maristella, Ambrosini, Valentina, Nannini, Margherita, Gatto, Lidia, Astolfi, Annalisa, Urbini, Milena, Indio, Valentina, Fanti, Stefano, Pantaleo, Maria Abbondanza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188102/
https://www.ncbi.nlm.nih.gov/pubmed/30344650
http://dx.doi.org/10.1177/1758835918793569
Descripción
Sumario:Cardiac tumors are a very rare condition. Mostly, they are benign tumors (75%), with myxomas being the most frequent. The remaining 25% are malignant; either primary malignant sarcoma or secondary metastases. Given the small number of cases reported and the lack of prospective and randomized clinical trials, the level of evidence for the optimal multimodal treatment of primary cardiac sarcomas is very low and the optimal imaging diagnostic workup is not well established. In particular, (18)F-FDG-PET/CT is not yet included in routine diagnosis of cardiac masses. Here, we report four illustrative clinical cases and a review of the literature on the current available data on the role of (18)F-fluorodeoxyglucose PET/CT imaging in cardiac tumors.

Ejemplares similares